Six-Foot Rule for Preventing the Spread of COVID-19 is Likely Useless, MIT Researchers Find
Ultimately this research shows that the 6-foot rule should not be a core component of COVID-19 spread mitigation strategies, says MIT professor.
New Updates to FDA Resource Page Provide Valuable Serology Test Information for Clinical Laboratories
What clinical laboratory leaders can expect to find.
FDA Recommends Healthcare Facilities Transition Away from Use of Decontaminated Disposable Respirators
Three new recommendations for respirator supply management.
FDA Issues Amendment to Streamline Authorization Process for Pooled COVID-19 Testing
Streamlining authorizations will allow growth of asymptomatic testing as part of school, workplace, community, and other COVID-19 testing programs.
Long-Haul COVID-19 Emerges as a Concern, Potentially Increasing Need for More COVID-19 Antibody Testing
Clinical laboratories would test for COVID-19 antibodies in those with long-haul COVID-19 symptoms but are unsure if they were ever infected with SARS-CoV-2.
FDA Revokes EUA for a Monoclonal Antibody Treatment, Citing Its Ineffectiveness in Treating SARS-CoV-2 Variants
EUA revocation indicates that SARS-CoV-2 mutations are beginning to impact COVID-19 treatment efficacies.
FDA and CDC Pause Use of Johnson and Johnson Vaccine Due to Rare Blood Clotting Disorder
Johnson and Johnson COVID-19 vaccine suspended as rare blood clotting disorder appears to be associated with the vaccine.
Nationwide COVID-19 Testing Program in Slovakia Proves the Effectiveness of a National Testing Program
The recent research on Slovakia’s national testing program provides a potential model for containing infectious disease outbreaks.
FDA Issues EUA for First Home Collected COVID-19 Antibody Test
This COVID-19 antibody test allows consumers to collect blood using a finger stick, then send the dried sample for laboratory analysis.
Clinical Laboratories Should Anticipate Gender-Dependent Differences in COVID-19 Antibody Levels, New Study Suggests
Clinical laboratories should be aware of the potential for quantitative differences in COVID-19 antibody levels, as demand for antibody testing may increase.